Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/11/1996EP0746334A1 Pharmaceutical preparation containing plasminogen activators
12/11/1996EP0746333A1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv)
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0746331A1 Convertible microemulsion formulations
12/11/1996EP0746202A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty
12/11/1996EP0646130B1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides
12/11/1996EP0625140B1 Cyclopropyl n-hydroxyurea and n-hydroxyacetamides which inhibit lipoxygenase
12/11/1996EP0496832B1 Inhibition of padgem-mediated cell binding
12/11/1996EP0437556B1 Substitution analogues of magainin peptides
12/11/1996CN1137826A Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders
12/11/1996CN1137758A Methods of prolonged suppression of humoral immunity
12/11/1996CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation
12/11/1996CN1137564A Stable transglutaminase preparations and processes for producing them
12/10/1996US5583238 Method for making intermediates useful in synthesis of retroviral protease inhibitors
12/10/1996US5583233 Retroviral protease inhibiting compounds
12/10/1996US5583232 Treating human immunodeficiency virus infections
12/10/1996US5583209 Produced by isolation and recombination of human and porcine factor viii
12/10/1996US5583202 Antigenized antibodies and genes
12/10/1996US5583146 Heterocyclic thrombin inhibitors
12/10/1996US5583116 Applying a polynucleotide primer to the colony tumor cell
12/10/1996US5583113 Use of a direct-acting thrombin inhibitor for the manufacture of a medicinal product having thrombolytic activity
12/10/1996US5583111 Water soluble leech extract
12/10/1996US5583109 Method of stimulating immune response
12/10/1996US5583108 Vasonatrin peptide and analogs thereof
12/10/1996US5583107 Agents affecting thrombosis and hemostasis
12/10/1996US5583106 Somatotropin for increasing reproductive performance in cattle
12/10/1996US5583105 Oral pharmaceutical preparation
12/10/1996US5583104 Treatment of proliferation of bile duct epithelium
12/10/1996US5583103 Inhibition of transforming growth factor beta activity
12/10/1996US5583102 Human thrombomodulin in wound healing
12/10/1996US5583101 S-nitroso amino acids
12/10/1996US5583046 Polypeptides
12/10/1996US5583034 Enhancement of adoptosis using antisense oligonucleotides
12/10/1996US5583031 Produced by expressing dna encoding alpha and beta polypeptides in insect cell
12/10/1996US5583011 Compositions, treatments, and diagnostics for Schistosomiasis and related diseases
12/10/1996US5583010 Nucleic acid molecule encoding the porcine growth hormone receptor
12/10/1996US5583002 Determining the level of expression of at least one selected t-cell antigen receptor protein or a protein in the t-lymnphocyte signal transduction pathway
12/10/1996US5582999 Methods for inhibition of intracellular transcription factor
12/10/1996US5582998 For demonstrating presence of tumor necrosis factor binding protein i in body fluids
12/10/1996US5582996 Bifunctional antibodies and method of preparing same
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582986 Oligonucleotide targeted to codon 12 of human h-ras gene, complementary and hybridizes to messenger rna to interfere with normal role in cell, causing loss of function
12/10/1996US5582972 Antisense oligonucleotides to the RAS gene
12/10/1996US5582862 Administering to treat myocardial infarction or blood clot
12/10/1996US5582835 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
12/10/1996US5582826 Monoclonal antibodies which bind the gamma chain of human interleukin-2 receptor
12/10/1996US5582825 Therapeutic medicine for cystic fibrosis
12/10/1996US5582824 Recombinant DES-CYS-TYR-CYS human immune interferon
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/10/1996US5582822 Cyclic administration of purified genetically engineered human interleukins
12/10/1996US5582821 Administering interleukins
12/10/1996US5582817 Organozinc compounds
12/10/1996US5582591 Delivery of solid drug compositions
12/10/1996CA2095636C N-halochitosans, their preparation and uses
12/10/1996CA2082270C Anti-viral therapy
12/10/1996CA2060507C Factor xa based anticoagulant compositions
12/10/1996CA2017285C Stabilized calcitonin pharmaceutical composition
12/10/1996CA2016949C Method and composition for the treatment of thrombosis in a mammal
12/10/1996CA2016659C Stabilized compositions containing epidermal growth factor
12/10/1996CA1338781C Ligands and methods for augmenting b-cell proliferation
12/10/1996CA1338777C Methods and compositions for preventing secondary cataracts
12/10/1996CA1338776C Use of transglutaminases as immunosuppressants
12/10/1996CA1338775C Water soluble monoesters as solubilisers for pharmacologicably active compounds and pharmaceutical excipients
12/08/1996CA2178538A1 Hepatitis gb virus synthetic peptides and uses thereof
12/08/1996CA2178537A1 Hepatitis gb virus recombinant proteins and uses thereof
12/08/1996CA2178526A1 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof
12/08/1996CA2178355A1 Diazepine containing dual action inhibitors
12/08/1996CA2178352A1 Thiazolo benzazepine containing dual action inhibitors
12/07/1996CA2178256A1 Oncostatin m induced hematopoiesis
12/05/1996WO1996038591A1 IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES
12/05/1996WO1996038588A1 Analytical and therapeutic agents
12/05/1996WO1996038571A2 Recombinant polypeptide cytotoxins for cancer treatment
12/05/1996WO1996038559A1 Chemokine n-terminal deletion mutations
12/05/1996WO1996038558A2 A human purinergic p2u receptor
12/05/1996WO1996038557A1 Hepatocyte growth factor receptor antagonists and uses thereof
12/05/1996WO1996038556A2 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
12/05/1996WO1996038555A2 Unc-53 from c. elegans and its uses in testing compounds involved in the control fo cell behaviour and pharmaceutical compositions
12/05/1996WO1996038550A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996WO1996038548A1 Oxygen activatable formulations for disinfection or sterilization
12/05/1996WO1996038543A1 Modified cells and methods for inhibiting xenograft rejection
12/05/1996WO1996038541A1 Long-term survival and regeneration of central nervous systems neurons
12/05/1996WO1996038540A1 Dna encoding cellular homologue of the sv40 large t antigen
12/05/1996WO1996038483A1 Monoclonal and polyclonal antibodies against recombinant human xanthine oxidase, method for their use and a kit containing same
12/05/1996WO1996038481A1 Anti-gp130 monoclonal antibodies
12/05/1996WO1996038480A1 Anti-inflammatory thrombospondin-derived peptides
12/05/1996WO1996038478A1 New dna molecules
12/05/1996WO1996038477A1 Novel antiproliferative protein from bacillus thuringiensis var. thuringiensis
12/05/1996WO1996038473A2 Antimicrobial cationic peptides
12/05/1996WO1996038471A1 Dipeptides which promote release of growth hormone
12/05/1996WO1996038470A1 IMIDAZO[1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
12/05/1996WO1996038463A1 Dna sequence and encoded mammary-specific breast cancer protein
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038435A1 Dopamine agonists
12/05/1996WO1996038178A1 Allogeneic and xenogeneic transplantation
12/05/1996WO1996038176A1 Leukemic cell growth inhibitor containing antisense oligonucleotide derivative against wilms' tumor gene (wt1)
12/05/1996WO1996038173A1 Brain edema inhibitor
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038170A1 Composition to improve digestibility and utilisation of nutrients
12/05/1996WO1996038169A1 Enteric coated compressed pancreatin particles
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
1 ... 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 ... 3163